Search clinical trials for: Evening only administration of insulin glargine
Total 601 results
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Poland, Slovakia, Canada, Slovenia, Greece, Czechia
-
SanofiCompleted
-
Amsterdam UMC, location VUmcCompletedType 2 Diabetes Mellitus | Congestive Heart FailureNetherlands
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Chile, Czech Republic, Denmark, France, Germany, Hungary, Lithuania, Mexico, Poland, Romania, Slovakia, Sweden
-
Mount Sinai Hospital, CanadaCanadian Institutes of Health Research (CIHR)Completed
-
Gan and Lee Pharmaceuticals, USACompletedDiabetes Mellitus, Type 1Spain, United States, Germany, Czechia, Hungary, Poland
-
SanofiCompletedDiabetesPeru, Ukraine, Colombia, Egypt, India, Indonesia, Israel, Jordan, Kuwait, Lebanon, Mexico, Philippines, Russian Federation, Saudi Arabia, Singapore, Taiwan, Thailand, United Arab Emirates
-
Emory UniversityCompletedPoor Glycemic ControlUnited States
-
SanofiCompleted
-
SanofiCompletedType 2 Diabetes MellitusGermany, United Kingdom
-
SanofiCompleted
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, India, Puerto Rico, Australia, Spain, Netherlands, Hungary, Brazil, Greece, Romania, Argentina
-
Washington University School of MedicineCompletedHyperglycemia | Lymphoma | Diabetes Mellitus, Type 2United States
-
University of New MexicoAmerican Diabetes AssociationCompleted
-
Xijing HospitalCompletedType 2 Diabetes MellitusChina
-
University of Colorado, DenverSanofiCompleted
-
Joslin Diabetes CenterSanofiCompleted
-
Diabetes Care CenterNovo Nordisk A/SCompleted
-
Northumbria UniversityNewcastle UniversityCompletedType 1 Diabetes MellitusUnited Kingdom
-
SanofiTerminatedType 2 Diabetes Mellitus | Renal ImpairmentUnited States, Czechia, Hungary, Poland, Serbia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesAustria, Hungary, Slovenia, Germany, Czech Republic, Poland, Slovakia
-
Mount Sinai Hospital, CanadaCanadian Institutes of Health Research (CIHR)Completed
-
SanofiCompletedDiabetes MellitusUnited States
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Taiwan, China, Korea, Republic of
-
SanofiCompletedType 1 Diabetes MellitusUnited States
-
Halozyme TherapeuticsCompletedDiabetes Mellitus, Type 1United States
-
SanofiCompletedType 2 DiabetesUnited States, Australia, Canada, Chile, Czech Republic, Denmark, Estonia, Hungary, Lithuania, Mexico, Netherlands, Poland, Romania, Russian Federation, Slovakia, Spain, Sweden, Ukraine
-
Halozyme TherapeuticsCompletedDiabetes Mellitus, Type 1United States
-
Brigham and Women's HospitalSanofiTerminatedType 2 DiabetesUnited States
-
Guillermo Umpierrez, MDMedical University of South Carolina; Sanofi; Texas A&M UniversityCompletedHyperglycemia | Type 2 DiabetesUnited States
-
Baylor College of MedicineCompletedHyperglycemia | Diabetes MellitusUnited States
-
Merck Sharp & Dohme LLCTerminated
-
HealthPartners InstituteSanofi; International Diabetes Center at Park NicolletCompletedHyperglycemiaUnited States
-
Vanderbilt University Medical CenterCompleted
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Brazil, Germany, Israel, Italy, United Kingdom, Australia, Hungary, Puerto Rico, Romania, Russian Federation, Spain, Poland, Canada, Greece, Turkey, Mexico, New Zealand, South Africa, Argentina, Finland, Lithuania, Sl...
-
University of Split, School of MedicinePavle Vrebalov Cindro; Jonatan Vuković; Darko Modun; Božo Smajić; Gordan Kardum; Tina... and other collaboratorsCompletedInsulin Glargine U300 vs Insulin Degludec U100 in Impact on the Glycaemic and Cardiovascular FactorsDiabetes Mellitus, Type 2Croatia
-
University of PennsylvaniaWithdrawnDiabetes MellitusUnited States
-
University of Sao Paulo General HospitalCompletedType 2 Diabetes Mellitus | Chronic Kidney DiseaseBrazil
-
Beijing Tongren HospitalUnknown
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Israel, Slovakia, Spain, France, Hungary, Mexico, Russian Federation, Turkey, Czechia, Greece, Argentina
-
LMC Diabetes & Endocrinology Ltd.SanofiCompletedType 2 Diabetes MellitusCanada
-
Medical University of South CarolinaCompletedHyperglycemia | Diabetes | Kidney TransplantationUnited States
-
SanofiCompletedType 2 Diabetes MellitusArgentina, Colombia, Egypt, Hong Kong, India, Indonesia, Lebanon, Malaysia, Peru, Philippines, Saudi Arabia, South Africa, Thailand, Turkey
-
Gan and Lee Pharmaceuticals, USACompletedDiabetes Mellitus, Type 2United States
-
Sandra SobelCompletedType 2 Diabetes MellitusUnited States
-
SanofiCompleted
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusItaly, Poland, Hungary, Mexico, Greece, Australia
-
SanofiCompletedType 2 DiabetesAustralia, Denmark, South Africa, Spain, Belgium, Russian Federation, Canada, Estonia, Hungary, Latvia, Mexico, United States, Chile, Czech Republic, France, Germany, Italy, Lithuania, Poland, Romania, Sweden, Ukraine, United Kingdom